To distill the relevant developments from the frontlines of cancer treatment, we asked a panel of experts for their two cents. See what they have to say about the state of molecular diagnostics, recent developments in personalized medicine and how the field of oncology itself is changing.

Gitte Pedersen, M.Sc.

CEO and Co-Founder, Genomic Expression

“The role of oncologist is moving toward team efforts where decisions are made by tumor boards.”

William Audeh, M.D.

Chief Medical Officer, Agendia

“Personalized medicine has given us a window into the inner workings of the cancer cell.”

Lawrence Marks M.D.

Professor and Chair, Department of Radiation Oncology, UNC

“There is evidence that molecular diagnostics can be used to help guide some decisions regarding drug therapies.”